GYS1 and breast cancer: We demonstrate that the key glycogen synthesis enzyme GYS1 is expressed in most primary breast tumors, especially in triple-negative and Ki67-high tumors, and that knockdown of GYS1 impairs breast cancer proliferation in vitro and in vivo and enhances sensitivity to targeting of mitochondrial protein homeostasis.